Talk to Geoffrey

+1 718 618 4302

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics, May 2013

You might be interested in: biotech, biomedical, biomaterials, more »

» Purchase Premium Reports

1-30 of about 2 600 reports
Analytical Tool - Antibodies and Peptides in Oncology

Analytical Tool - Antibodies and Peptides in Oncology

  • $ 8 925
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool - Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and ...

  • Industries : Biopharmaceutical
U.S. Dental Bone Graft Substitutes and Other Biomaterials Market

U.S. Dental Bone Graft Substitutes and Other Biomaterials Market

  • $ 6 995
  • Industry report
  • May 2013
  • by iData Research, Inc.

Declining sales of specific market products has resulted in decelerating growth of the total U.S. denta bone graft substitute and other biomaterials market in 2012. In 2012, the total U.S. market for dental ...

  • Industries : Biomaterial
  • Countries : United States
Analytical Tool - Cancer Immunotherapy

Analytical Tool - Cancer Immunotherapy

  • $ 8 175
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...

  • Industries : Biological Therapy
iPS cell Generation patent landscape - 2013/03

iPS cell Generation patent landscape - 2013/03

  • $ 6 860
  • Industry report
  • May 2013
  • by France Innovation Scientifique et Transfert

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, China
U.S. qPCR Reagents Market

U.S. qPCR Reagents Market

  • $ 6 000
  • Industry report
  • April 2013
  • by Frost & Sullivan

Finding Opportunities in a Changing Competitive and Patent Landscape This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : United States
Proteomics: Technologies and Global Markets

Proteomics: Technologies and Global Markets

  • $ 5 450
  • Industry report
  • May 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES BCC Research's goal for this study was to determine the status of proteomic technologies and products and assess their global growth potential over the five-year period from ...

  • Industries : Genomics
  • Countries : World
Bioinformatics: Technologies and Global Markets

Bioinformatics: Technologies and Global Markets

  • $ 5 450
  • Industry report
  • April 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES BCC Research's goal for this study is to provide a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high-throughput ?omic technologies and ...

  • Industries : Genomics
  • Countries : World
Electrophoresis Technology: Global Markets

Electrophoresis Technology: Global Markets

  • $ 5 450
  • Industry report
  • April 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES This report is an update of an earlier (2008) BCC report on the worldwide electrophoresis industry. This report will 'determine the current status of the electrophoresis industry ...

  • Industries : Genomics
  • Countries : World
Nanomagnetics: Materials, Devices and Markets

Nanomagnetics: Materials, Devices and Markets

  • $ 5 450
  • Industry report
  • April 2013
  • by BCC Research

STUDY GOALS AND OBJECTIVES In 2007, the Nobel Prize Committee stated that, ?Giant magnetoresistance (GMR) can be considered one of the first real applications of the promising field of nanotechnology.? ...

  • Industries : Nanotechnology, Biotechnology
  • Countries : World
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

  • $ 5 450
  • Industry report
  • March 2013
  • by BCC Research

REPORT SCOPE INTRODUCTION Biomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, indicate what treatment options ...

  • Industries : Genomics
  • Countries : World
Analytical Tool - Cancer Therapeutic Antibodies

Analytical Tool - Cancer Therapeutic Antibodies

  • $ 5 924
  • Industry report
  • April 2013
  • by Bioseeker

"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. ...

  • Industries : Biological Therapy
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

  • $ 4 650
  • Industry report
  • March 2013
  • by MarketsandMarkets

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently ...

  • Industries : Biopharmaceutical
  • Countries : World
Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] - Global Forecasts to 2017

Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] - Global Forecasts to 2017

  • $ 4 650
  • Industry report
  • March 2013
  • by MarketsandMarkets

A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2000 years ago, when ...

  • Industries : Biomaterial
  • Countries : World
Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Market - Global Industry Analysis, Size, Share, Growth, Trends And

Computational Biology (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) Market - Global Industry Analysis, Size, Share, Growth, Trends And

  • $ 4 595
  • Industry report
  • May 2013
  • by Transparency Market Research

The computational biology market is predicted to have a notable growth owing to its wide use by biotechnology and pharmaceutical companies to reduce the incidences of late stage failures of their drugs ...

  • Industries : Genomics
  • Countries : World
Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast

Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast

  • $ 4 595
  • Industry report
  • April 2013
  • by Transparency Market Research

The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the ...

  • Industries : Genomics
  • Countries : World
Triple Analysis: Cancer Vaccines, Antibodies and Peptides

Triple Analysis: Cancer Vaccines, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • March 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Cancer Vaccines and by the two compound strategies of Antibodies and Peptides. Each of these three individual ...

  • Industries : Biopharmaceutical
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies

Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies

  • $ 5 175
  • Industry report
  • March 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors and by the compound strategy of Antibodies. ...

  • Industries : Biopharmaceutical
Triple Analysis: Leukemia, Cancer Vaccines and Antibodies

Triple Analysis: Leukemia, Cancer Vaccines and Antibodies

  • $ 5 175
  • Industry report
  • March 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...

  • Industries : Biopharmaceutical
Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies

Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies

  • $ 5 175
  • Industry report
  • March 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...

  • Industries : Biopharmaceutical
Triple Analysis: Melanoma, Cancer Vaccines and Antibodies

Triple Analysis: Melanoma, Cancer Vaccines and Antibodies

  • $ 5 175
  • Industry report
  • March 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...

  • Industries : Biopharmaceutical
iPS cell Differentiation patent landscape - 2013/03

iPS cell Differentiation patent landscape - 2013/03

  • $ 4 060
  • Industry report
  • May 2013
  • by France Innovation Scientifique et Transfert

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, China
Antibody Technologies and Attrition Rates - an industry analysis 2013

Antibody Technologies and Attrition Rates - an industry analysis 2013

  • $ 3 238
  • Industry report
  • March 2013
  • by La Merie Publishing

Product Description The report ?Antibody Technologies and Attrition Rates - an industry analysis 2013? is based on the identification of the antibody generation technologies of 504 naked antibodies in ...

  • Industries : Biopharmaceutical
Immunotherapy in Oncology Drug Pipeline Update 2013

Immunotherapy in Oncology Drug Pipeline Update 2013

  • $ 3 675
  • Industry report
  • April 2013
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

  • Industries : Biological Therapy
Antibody Partnering Terms and Agreements

Antibody Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • May 2013
  • by Currentpartnering

The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pharmacogenomics Partnering Terms and Agreements

Pharmacogenomics Partnering Terms and Agreements

  • $ 2 795
  • Industry report
  • April 2013
  • by Currentpartnering

The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds ...

  • Industries : Genomics
  • Countries : United States
Biomarker Partnering Terms and Agreements

Biomarker Partnering Terms and Agreements

  • $ 2 795
  • Industry report
  • March 2013
  • by Currentpartnering

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Genomics
Top Ten Suppliers of Synthetic Biology Technology

Top Ten Suppliers of Synthetic Biology Technology

  • $ 2 550
  • Industry report
  • March 2013
  • by BCC Research

INTRODUCTION Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World, United Kingdom
Biomaterials China News 1304 - Annual Subscription

Biomaterials China News 1304 - Annual Subscription

  • $ 2 511
  • Industry report
  • April 2013
  • by CCM International Limited

Editor Notes In March 2013, a series of policies related to the biomaterials industry were published in China. The Chinese government paid more attention to green agriculture and environmental protection. ...

  • Industries : Biomaterial
  • Countries : China
Biomaterials China News 1303

Biomaterials China News 1303

  • $ 2 511
  • Industry report
  • March 2013
  • by CCM International Limited

Editor Notes Feb. 2013 is the first month of the traditional Chinese year, and many enterprises have already published their performance pre-announcement for the year 2012. Some witnessed a better-than-expected ...

  • Industries : Biomaterial
  • Countries : China
Advances in Clinical Genome Sequencing and Diagnostics - Overview

Advances in Clinical Genome Sequencing and Diagnostics - Overview

  • $ 2 495
  • Industry report
  • March 2013
  • by CHI Insight Pharma Reports

This report explores the recent surge in clinical genome sequencing, from the point of view of the sequencing providers, the medical organizations delivering these services, and the start-ups offering ...

  • Industries : Genomics
  • Countries : United States

» Download Public Reports

About 6 200 reports
Intercell AG - Company Report for Year 2013

Intercell AG - Company Report for Year 2013

  • Company report
  • May 2013
  • 4 pages

... And production of rare, fully human monoclonal antibodies are offered by vivalis. Through these programs, vivalis receives payments associated with the funding of discovery research, an upfront payment, clinical ...


» Read our Company Profiles

99 Companies

Nutrition Co.

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.